Hawaii 2022 Regular Session

Hawaii House Bill HB2173 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	HOUSE OF REPRESENTATIVES H.B. NO. 2173 THIRTY-FIRST LEGISLATURE, 2022 STATE OF HAWAII A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
2	2
3	3	HOUSE OF REPRESENTATIVES H.B. NO. 2173
4	4	THIRTY-FIRST LEGISLATURE, 2022
5	5	STATE OF HAWAII
6	6
7	7	HOUSE OF REPRESENTATIVES
8	8
9	9	H.B. NO.
10	10
11	11	2173
12	12
13	13	THIRTY-FIRST LEGISLATURE, 2022
14	14
15	15
16	16
17	17	STATE OF HAWAII
18	18
19	19
20	20
21	21
22	22
23	23
24	24
25	25
26	26
27	27
28	28
29	29
30	30
31	31	A BILL FOR AN ACT
32	32
33	33
34	34
35	35
36	36
37	37	RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.
38	38
39	39
40	40
41	41
42	42
43	43	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
44	44
45	45
46	46
47	47	SECTION 1. Section 329-14, Hawaii Revised Statutes, is amended as follows: (1) By amending subsection (b) to read as follows: "(b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide); (2) Acetylmethadol; (3) Allylprodine; (4) Alphacetylmethadol (except levo-alphacetylmethadol, levomethadyl acetate, or LAAM); (5) Alphameprodine; (6) Alphamethadol; (7) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine); (8) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); (9) Benzethidine; (10) Betacetylmethadol; (11) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide); (12) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide); (13) Betameprodine; (14) Betamethadol; (15) Betaprodine; (16) Clonitazene; (17) Dextromoramide; (18) Diampromide; (19) Diethylthiambutene; (20) Difenoxin; (21) Dimenoxadol; (22) Dimepheptanol; (23) Dimethylthiambutene; (24) Dioxaphetyl butyrate; (25) Dipipanone; (26) Ethylmethylthiambutene; (27) Etonitazene; (28) Etoxeridine; (29) Furethidine; (30) Hydroxypethidine; (31) Ketobemidone; (32) Levomoramide; (33) Levophenacylmorphan; (34) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide); (35) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); (36) Morpheridine; (37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); (38) Noracymethadol; (39) Norlevorphanol; (40) Normethadone; (41) Norpipanone; (42) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide; (43) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine; (44) Phenadoxone; (45) Phenampromide; (46) Phenomorphan; (47) Phenoperidine; (48) Piritramide; (49) Proheptazine; (50) Properidine; (51) Propiram; (52) Racemoramide; (53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide); (54) Tilidine; (55) Trimeperidine; (56) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts, and salts of isomers; (57) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts, and salts of isomers; (58) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, (acetyl fentanyl), its optical, positional, and geometric isomers, salts, and salts of isomers; (59) AH-7921 (3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide), its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers; (60) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: Butyryl fentanyl); (61) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, its isomers, esters, ethers, salts and salts of isomers, esters, and ethers (Other names: beta-hydroxythiofentanyl); (62) N-(1-phenthylpiperidin-4-y1)-N-phenylfuran-2-carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: Furanyl fentanyl); (63) 3,4-dicholoro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: U-47700); (64) 4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl [N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide]; (65) Acryl fentanyl or acryloylfentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide]; (66) Ocfentanil [N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide]; (67) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide; (68) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); (69) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 2-fluorofentanyl); [and] (70) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide)[.]; (71) N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (2'-fluoro ortho-fluorofentanyl; 2'-fluoro 2-fluorofentanyl); (72) N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide(4'-methyl acetyl fentanyl); (73) N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide (β'-phenyl fentanyl; beta'-Phenyl fentanyl; 3-phenylpropanoyl fentanyl); (74) N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide β-methyl fentanyl); (75) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide(ortho-fluorobutyryl fentanyl; 2-fluorobutyryl fentanyl); (76) N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide(ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl); (77) 2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl methoxyacetylfentanyl; 2-methyl methoxyacetyl fentanyl); (78) N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4-methylfentanyl); (79) N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (phenyl fentanyl; benzoyl fentanyl); (80) N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide (thiofuranyl fentanyl); 2-thiofuranyl fentanyl; thiophene fentanyl; (81) Ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate (fentanyl carbamate); (82) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide(ortho-fluoroacryl fentanyl); (83) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (ortho-fluoroisobutyryl fentanyl); and (84) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide (para-fluoro furanyl fentanyl)." (2) By amending subsection (f) to read as follows: "(f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, somers, and salts of isomers: (1) Aminorex; (2) Cathinone; (3) Fenethylline; (4) Methcathinone; (5) N-ethylamphetamine; (6) 4-methylaminorex; (7) N,N-dimethylamphetamine; [and] (8) Substituted cathinones, any compound, except bupropion or compounds listed under a different schedule, structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways: (A) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents; (B) By substitution at the 3-position with an acyclic alkyl substituent; or (C) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure. Some other trade names: Mephedrone (2-methylamino-1-p-tolylpropan-1-one), also known as 4-methylmethcathinone (4-MMC), methylephedrone or MMCAT; Methylenedioxypyrovalerone (MDPV, MDPK); methylone or 3,4-methylenedioxymethcathinone; and 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-one, monohydrochloride, also known as Ethylone, bk-MDEA hydrochloride, MDEC; 3,4-Methylenedioxy-N-ethylcathinone; bk-Methylenedioxyethylamphetamine, 4-methyl-N-ethylcathinone (4-MEC); 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP); alpha-pyrrolidinopentiophenone ([alpha]-PVP); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB e); 2-(methylamino)-1-phenylpentan-1-one (pentedrone); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP); 4-fluoro-N-methylcathinone (4-FMC, flephedrone); 3-fluoro-N-methylcathinone (3-FMC); 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone); alpha-pyrrolidinobutiophenone ([alpha]-PBP) and their optical, positional, and geometric isomers, salts and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible[.]; (9) 4,4'-dimethylaminorex (common name: 4,4'-DMAR) including its salts, isomers, and salts of isomers; and (10) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (para-methoxymethamphetamine, PMMA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation." (3) By amending subsection (g) to read as follows: "(g) Any of the following cannabinoids, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Tetrahydrocannabinols; meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: Delta 1 cis or trans tetrahydrocannabinol, and their optical isomers; Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; and Delta 3,4 cis or trans-tetrahydrocannabinol, and its optical isomers (since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions, are covered); (2) Naphthoylindoles; meaning any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl,cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent; (3) Naphthylmethylindoles; meaning any compound containing a 1H-indol-3-yl-(1-naphthyl) methane structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent; (4) Naphthoylpyrroles; meaning any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent; (5) Naphthylmethylindenes; meaning any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent; (6) Phenylacetylindoles; meaning any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent; (7) Cyclohexylphenols; meaning any compound containing a 2-(3-hydroxycyclohexyl) phenol structure with substitution at the 5-position of the phenolic ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not substituted in the cyclohexyl ring to any extent; (8) Benzoylindoles; meaning any compound containing a 3-(benzoyl) indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent; (9) [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo[1,2,3-de]-1, 4-benzoxazin-6-yl]-1-naphthalenylmethanone (another trade name is WIN 55,212-2); (10) (6a,10a)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (Other trade names are: HU-210/HU-211); (11) Tetramethylcyclopropanoylindoles; meaning any compound containing a 3-tetramethylcyclopropanoylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the tetramethylcyclopropyl ring to any extent; (12) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: APINACA, AKB48); (13) Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: PB-22; QUPIC); (14) Quinolin-8-yl 1-(5fluoropentyl)-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 5-fluoro-PB-22; 5F-PB-22); (15) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-FUBINACA); (16) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: ADB-PINACA); (17) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-CHMINACA); (18) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: AB-PINACA); (19) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone, and geometric isomers, salts, and salts of isomers (Other names: THJ-2201); (20) Methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate, and geometric isomers, salts, and salts of isomers (Other names: FUB-AMB, Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, MMB-FUBINACA, AMB-FUBINACA); (21) (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, and geometric isomers, salts, and salts of isomers (Other names: 5-fluoro-AMB, 5-fluoro-AMP); (22) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: AKB48 N-(5-fluoropentyl) analog, 5F-AKB48, APINACA 5-fluoropentyl analog, 5F-APINACA); (23) N-adamantyl-1-fluoropentylindole-3-Carboxamide, and geometric isomers, salts, and salts of isomers (Other names: STS-135, 5F-APICA; 5-fluoro-APICA); (24) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, and geometric isomers, salts, and salts of isomers (Other names: NM2201); (25) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: MAB-CHMINACA and ADB-CHMINACA); (26) Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (Other names: 5F-ADB, 5-flouro-ADB, and 5F-MDMB-PINACA), its optical, positional, and geometric isomers, salts, and salts of isomers; [and] (27) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA), its optical, positional, and geometric isomers, salts, and salts of isomers; also known as SGT-78, 4-CN-CUMYL-BINACA; CUMYL-CB-PINACA; CUMYL-CYBINACA; 4-cyano CUMYL-BUTINACA[.]; (28) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (Other names: NM2201 or CBL2201); (29) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other names: 5F-AB-PINACA); (30) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA, 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, or SGT-78); (31) Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA or AMB-CHMICA); (32) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other names: 5F-CUMYL-P7AICA); and (33) Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (MDMB-4en-PINACA)." SECTION 2. Section 329-16, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows: "(c) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Alfentanil; (2) Alphaprodine; (3) Anileridine; (4) Bezitramide; (5) Bulk Dextropropoxyphene (nondosage form); (6) Carfentanil; (7) Dihydrocodeine; (8) Diphenoxylate; (9) Fentanyl; (10) Isomethadone; (11) Levo-alphacetylmethadol (LAAM); (12) Levomethorphan; (13) Levorphanol; (14) Metazocine; (15) Methadone; (16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane; (17) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic acid; (18) Pethidine (Meperidine); (19) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine; (20) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate; (21) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid; (22) Phenazocine; (23) Piminodine; (24) Racemethorphan; (25) Racemorphan; (26) Remifentanil; (27) Sufentanil; (28) Tapentadol; [and] (29) Thiafentanil[.]; and (30) Oliceridine, including the free base form, and its salts, to include the fumarate salt, by definition." SECTION 3. Section 329-20, Hawaii Revised Statutes, is amended as follows: (1) By amending subsection (b) to read as follows: "(b) Depressants. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, esters, ethers, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, that has a degree of danger or probable danger associated with a depressant effect on the central nervous system: (1) Alprazolam; (2) Barbital; (3) Bromazepam; (4) Butorphanol; (5) Camazepam; (6) Carisoprodol; (7) Chloral betaine; (8) Chloral hydrate; (9) Chlordiazepoxide; (10) Clobazam; (11) Clonazepam; (12) Clorazepate; (13) Clotiazepam; (14) Cloxazolam; (15) Delorazepam; (16) Dichloralphenazone (Midrin); (17) Diazepam; (18) Estazolam; (19) Ethchlorvynol; (20) Ethinamate; (21) Ethyl loflazepate; (22) Fludiazepam; (23) Flunitrazepam; (24) Flurazepam; (25) Fospropofol (Lusedra); (26) Halazepam; (27) Haloxazolam; (28) Ketazolam; (29) Loprazolam; (30) Lorazepam; (31) Lormetazepam; (32) Mebutamate; (33) Medazepam; (34) Meprobamate; (35) Methohexital; (36) Methylphenobarbital (mephorbarbital); (37) Midazolam; (38) Nimetazepam; (39) Nitrazepam; (40) Nordiazepam; (41) Oxazepam; (42) Oxazolam; (43) Paraldehyde; (44) Petrichloral; (45) Phenobarbital; (46) Pinazepam; (47) Prazepam; (48) Quazepam; (49) Suvorexant; (50) Temazepam; (51) Tetrazepam; (52) Triazolam; (53) Zaleplon; (54) Zolpidem; (55) Zopiclone (Lunesta); [and] (56) Brexanolone[.]; (57) Remimazolam, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible; and (58) Lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible." (2) By amending subsection (d) to read as follows: "(d) Stimulants. Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Cathine ((+)-norpseudoephedrine); (2) Diethylpropion; (3) Fencamfamin; (4) Fenproporex; (5) Mazindol; (6) Mefenorex; (7) Modafinil; (8) Phentermine; (9) Pemoline (including organometallic complexes and chelates thereof); (10) Pipradrol; (11) Sibutramine; (12) SPA (1-dimethylamino-1,2-diphenylethane, lefetamine); (13) Lorcaserin; [and] (14) Solriamfetol[.]; and (15) Serdexmethylphenidate, including its salts, isomers, and salts of isomers." SECTION 4. Section 329-22, Hawaii Revised Statutes, is amended by amending subsection (d) to read as follows: "(d) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers: (1) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy- propionamide], (Vimpat); (2) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid]; [and] (3) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) (Other names: BRV; UCB-34714; Briviact) and its salts[.]; and (4) Lasmiditan (2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide)." SECTION 5. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored. SECTION 6. This Act shall take effect upon its approval. INTRODUCED BY: _____________________________ BY REQUEST
48	48
49	49	SECTION 1. Section 329-14, Hawaii Revised Statutes, is amended as follows:
50	50
51	51	(1) By amending subsection (b) to read as follows:
52	52
53	53	"(b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:
54	54
55	55	(1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
56	56
57	57	(2) Acetylmethadol;
58	58
59	59	(3) Allylprodine;
60	60
61	61	(4) Alphacetylmethadol (except levo-alphacetylmethadol, levomethadyl acetate, or LAAM);
62	62
63	63	(5) Alphameprodine;
64	64
65	65	(6) Alphamethadol;
66	66
67	67	(7) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
68	68
69	69	(8) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
70	70
71	71	(9) Benzethidine;
72	72
73	73	(10) Betacetylmethadol;
74	74
75	75	(11) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);
76	76
77	77	(12) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
78	78
79	79	(13) Betameprodine;
80	80
81	81	(14) Betamethadol;
82	82
83	83	(15) Betaprodine;
84	84
85	85	(16) Clonitazene;
86	86
87	87	(17) Dextromoramide;
88	88
89	89	(18) Diampromide;
90	90
91	91	(19) Diethylthiambutene;
92	92
93	93	(20) Difenoxin;
94	94
95	95	(21) Dimenoxadol;
96	96
97	97	(22) Dimepheptanol;
98	98
99	99	(23) Dimethylthiambutene;
100	100
101	101	(24) Dioxaphetyl butyrate;
102	102
103	103	(25) Dipipanone;
104	104
105	105	(26) Ethylmethylthiambutene;
106	106
107	107	(27) Etonitazene;
108	108
109	109	(28) Etoxeridine;
110	110
111	111	(29) Furethidine;
112	112
113	113	(30) Hydroxypethidine;
114	114
115	115	(31) Ketobemidone;
116	116
117	117	(32) Levomoramide;
118	118
119	119	(33) Levophenacylmorphan;
120	120
121	121	(34) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);
122	122
123	123	(35) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
124	124
125	125	(36) Morpheridine;
126	126
127	127	(37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
128	128
129	129	(38) Noracymethadol;
130	130
131	131	(39) Norlevorphanol;
132	132
133	133	(40) Normethadone;
134	134
135	135	(41) Norpipanone;
136	136
137	137	(42) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide;
138	138
139	139	(43) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine;
140	140
141	141	(44) Phenadoxone;
142	142
143	143	(45) Phenampromide;
144	144
145	145	(46) Phenomorphan;
146	146
147	147	(47) Phenoperidine;
148	148
149	149	(48) Piritramide;
150	150
151	151	(49) Proheptazine;
152	152
153	153	(50) Properidine;
154	154
155	155	(51) Propiram;
156	156
157	157	(52) Racemoramide;
158	158
159	159	(53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);
160	160
161	161	(54) Tilidine;
162	162
163	163	(55) Trimeperidine;
164	164
165	165	(56) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts, and salts of isomers;
166	166
167	167	(57) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts, and salts of isomers;
168	168
169	169	(58) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, (acetyl fentanyl), its optical, positional, and geometric isomers, salts, and salts of isomers;
170	170
171	171	(59) AH-7921 (3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide), its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers;
172	172
173	173	(60) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: Butyryl fentanyl);
174	174
175	175	(61) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, its isomers, esters, ethers, salts and salts of isomers, esters, and ethers (Other names: beta-hydroxythiofentanyl);
176	176
177	177	(62) N-(1-phenthylpiperidin-4-y1)-N-phenylfuran-2-carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: Furanyl fentanyl);
178	178
179	179	(63) 3,4-dicholoro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: U-47700);
180	180
181	181	(64) 4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl [N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide];
182	182
183	183	(65) Acryl fentanyl or acryloylfentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide];
184	184
185	185	(66) Ocfentanil [N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide];
186	186
187	187	(67) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide;
188	188
189	189	(68) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
190	190
191	191	(69) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 2-fluorofentanyl); [and]
192	192
193	193	(70) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide)[.];
194	194
195	195	(71) N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (2'-fluoro ortho-fluorofentanyl; 2'-fluoro 2-fluorofentanyl);
196	196
197	197	(72) N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide(4'-methyl acetyl fentanyl);
198	198
199	199	(73) N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide (β'-phenyl fentanyl; beta'-Phenyl fentanyl; 3-phenylpropanoyl fentanyl);
200	200
201	201	(74) N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide β-methyl fentanyl);
202	202
203	203	(75) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide(ortho-fluorobutyryl fentanyl; 2-fluorobutyryl fentanyl);
204	204
205	205	(76) N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide(ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl);
206	206
207	207	(77) 2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl methoxyacetylfentanyl; 2-methyl methoxyacetyl fentanyl);
208	208
209	209	(78) N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4-methylfentanyl);
210	210
211	211	(79) N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (phenyl fentanyl; benzoyl fentanyl);
212	212
213	213	(80) N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide (thiofuranyl fentanyl); 2-thiofuranyl fentanyl; thiophene fentanyl;
214	214
215	215	(81) Ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate (fentanyl carbamate);
216	216
217	217	(82) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide(ortho-fluoroacryl fentanyl);
218	218
219	219	(83) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (ortho-fluoroisobutyryl fentanyl); and
220	220
221	221	(84) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide (para-fluoro furanyl fentanyl)."
222	222
223	223	(2) By amending subsection (f) to read as follows:
224	224
225	225	"(f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, somers, and salts of isomers:
226	226
227	227	(1) Aminorex;
228	228
229	229	(2) Cathinone;
230	230
231	231	(3) Fenethylline;
232	232
233	233	(4) Methcathinone;
234	234
235	235	(5) N-ethylamphetamine;
236	236
237	237	(6) 4-methylaminorex;
238	238
239	239	(7) N,N-dimethylamphetamine; [and]
240	240
241	241	(8) Substituted cathinones, any compound, except bupropion or compounds listed under a different schedule, structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways:
242	242
243	243	(A) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;
244	244
245	245	(B) By substitution at the 3-position with an acyclic alkyl substituent; or
246	246
247	247	(C) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure.
248	248
249	249	Some other trade names: Mephedrone (2-methylamino-1-p-tolylpropan-1-one), also known as 4-methylmethcathinone (4-MMC), methylephedrone or MMCAT; Methylenedioxypyrovalerone (MDPV, MDPK); methylone or 3,4-methylenedioxymethcathinone; and 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-one, monohydrochloride, also known as Ethylone, bk-MDEA hydrochloride, MDEC; 3,4-Methylenedioxy-N-ethylcathinone; bk-Methylenedioxyethylamphetamine, 4-methyl-N-ethylcathinone (4-MEC); 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP); alpha-pyrrolidinopentiophenone ([alpha]-PVP); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB e); 2-(methylamino)-1-phenylpentan-1-one (pentedrone); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP); 4-fluoro-N-methylcathinone (4-FMC, flephedrone); 3-fluoro-N-methylcathinone (3-FMC); 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone); alpha-pyrrolidinobutiophenone ([alpha]-PBP) and their optical, positional, and geometric isomers, salts and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible[.];
250	250
251	251	(9) 4,4'-dimethylaminorex (common name: 4,4'-DMAR) including its salts, isomers, and salts of isomers; and
252	252
253	253	(10) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (para-methoxymethamphetamine, PMMA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation."
254	254
255	255	(3) By amending subsection (g) to read as follows:
256	256
257	257	"(g) Any of the following cannabinoids, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
258	258
259	259	(1) Tetrahydrocannabinols; meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: Delta 1 cis or trans tetrahydrocannabinol, and their optical isomers; Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; and Delta 3,4 cis or trans-tetrahydrocannabinol, and its optical isomers (since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions, are covered);
260	260
261	261	(2) Naphthoylindoles; meaning any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl,cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent;
262	262
263	263	(3) Naphthylmethylindoles; meaning any compound containing a 1H-indol-3-yl-(1-naphthyl) methane structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent;
264	264
265	265	(4) Naphthoylpyrroles; meaning any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;
266	266
267	267	(5) Naphthylmethylindenes; meaning any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;
268	268
269	269	(6) Phenylacetylindoles; meaning any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent;
270	270
271	271	(7) Cyclohexylphenols; meaning any compound containing a 2-(3-hydroxycyclohexyl) phenol structure with substitution at the 5-position of the phenolic ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not substituted in the cyclohexyl ring to any extent;
272	272
273	273	(8) Benzoylindoles; meaning any compound containing a 3-(benzoyl) indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent;
274	274
275	275	(9) [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo[1,2,3-de]-1, 4-benzoxazin-6-yl]-1-naphthalenylmethanone (another trade name is WIN 55,212-2);
276	276
277	277	(10) (6a,10a)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (Other trade names are: HU-210/HU-211);
278	278
279	279	(11) Tetramethylcyclopropanoylindoles; meaning any compound containing a 3-tetramethylcyclopropanoylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the tetramethylcyclopropyl ring to any extent;
280	280
281	281	(12) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: APINACA, AKB48);
282	282
283	283	(13) Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: PB-22; QUPIC);
284	284
285	285	(14) Quinolin-8-yl 1-(5fluoropentyl)-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 5-fluoro-PB-22; 5F-PB-22);
286	286
287	287	(15) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-FUBINACA);
288	288
289	289	(16) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: ADB-PINACA);
290	290
291	291	(17) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-CHMINACA);
292	292
293	293	(18) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: AB-PINACA);
294	294
295	295	(19) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone, and geometric isomers, salts, and salts of isomers (Other names: THJ-2201);
296	296
297	297	(20) Methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate, and geometric isomers, salts, and salts of isomers (Other names: FUB-AMB, Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, MMB-FUBINACA, AMB-FUBINACA);
298	298
299	299	(21) (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, and geometric isomers, salts, and salts of isomers (Other names: 5-fluoro-AMB, 5-fluoro-AMP);
300	300
301	301	(22) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: AKB48 N-(5-fluoropentyl) analog, 5F-AKB48, APINACA 5-fluoropentyl analog, 5F-APINACA);
302	302
303	303	(23) N-adamantyl-1-fluoropentylindole-3-Carboxamide, and geometric isomers, salts, and salts of isomers (Other names: STS-135, 5F-APICA; 5-fluoro-APICA);
304	304
305	305	(24) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, and geometric isomers, salts, and salts of isomers (Other names: NM2201);
306	306
307	307	(25) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: MAB-CHMINACA and ADB-CHMINACA);
308	308
309	309	(26) Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (Other names: 5F-ADB, 5-flouro-ADB, and 5F-MDMB-PINACA), its optical, positional, and geometric isomers, salts, and salts of isomers; [and]
310	310
311	311	(27) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA), its optical, positional, and geometric isomers, salts, and salts of isomers; also known as SGT-78, 4-CN-CUMYL-BINACA; CUMYL-CB-PINACA; CUMYL-CYBINACA; 4-cyano CUMYL-BUTINACA[.];
312	312
313	313	(28) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (Other names: NM2201 or CBL2201);
314	314
315	315	(29) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other names: 5F-AB-PINACA);
316	316
317	317	(30) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA, 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, or SGT-78);
318	318
319	319	(31) Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA or AMB-CHMICA);
320	320
321	321	(32) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other names: 5F-CUMYL-P7AICA); and
322	322
323	323	(33) Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (MDMB-4en-PINACA)."
324	324
325	325	SECTION 2. Section 329-16, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows:
326	326
327	327	"(c) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:
328	328
329	329	(1) Alfentanil;
330	330
331	331	(2) Alphaprodine;
332	332
333	333	(3) Anileridine;
334	334
335	335	(4) Bezitramide;
336	336
337	337	(5) Bulk Dextropropoxyphene (nondosage form);
338	338
339	339	(6) Carfentanil;
340	340
341	341	(7) Dihydrocodeine;
342	342
343	343	(8) Diphenoxylate;
344	344
345	345	(9) Fentanyl;
346	346
347	347	(10) Isomethadone;
348	348
349	349	(11) Levo-alphacetylmethadol (LAAM);
350	350
351	351	(12) Levomethorphan;
352	352
353	353	(13) Levorphanol;
354	354
355	355	(14) Metazocine;
356	356
357	357	(15) Methadone;
358	358
359	359	(16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
360	360
361	361	(17) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic acid;
362	362
363	363	(18) Pethidine (Meperidine);
364	364
365	365	(19) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
366	366
367	367	(20) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
368	368
369	369	(21) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
370	370
371	371	(22) Phenazocine;
372	372
373	373	(23) Piminodine;
374	374
375	375	(24) Racemethorphan;
376	376
377	377	(25) Racemorphan;
378	378
379	379	(26) Remifentanil;
380	380
381	381	(27) Sufentanil;
382	382
383	383	(28) Tapentadol; [and]
384	384
385	385	(29) Thiafentanil[.]; and
386	386
387	387	(30) Oliceridine, including the free base form, and its salts, to include the fumarate salt, by definition."
388	388
389	389	SECTION 3. Section 329-20, Hawaii Revised Statutes, is amended as follows:
390	390
391	391	(1) By amending subsection (b) to read as follows:
392	392
393	393	"(b) Depressants. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, esters, ethers, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, that has a degree of danger or probable danger associated with a depressant effect on the central nervous system:
394	394
395	395	(1) Alprazolam;
396	396
397	397	(2) Barbital;
398	398
399	399	(3) Bromazepam;
400	400
401	401	(4) Butorphanol;
402	402
403	403	(5) Camazepam;
404	404
405	405	(6) Carisoprodol;
406	406
407	407	(7) Chloral betaine;
408	408
409	409	(8) Chloral hydrate;
410	410
411	411	(9) Chlordiazepoxide;
412	412
413	413	(10) Clobazam;
414	414
415	415	(11) Clonazepam;
416	416
417	417	(12) Clorazepate;
418	418
419	419	(13) Clotiazepam;
420	420
421	421	(14) Cloxazolam;
422	422
423	423	(15) Delorazepam;
424	424
425	425	(16) Dichloralphenazone (Midrin);
426	426
427	427	(17) Diazepam;
428	428
429	429	(18) Estazolam;
430	430
431	431	(19) Ethchlorvynol;
432	432
433	433	(20) Ethinamate;
434	434
435	435	(21) Ethyl loflazepate;
436	436
437	437	(22) Fludiazepam;
438	438
439	439	(23) Flunitrazepam;
440	440
441	441	(24) Flurazepam;
442	442
443	443	(25) Fospropofol (Lusedra);
444	444
445	445	(26) Halazepam;
446	446
447	447	(27) Haloxazolam;
448	448
449	449	(28) Ketazolam;
450	450
451	451	(29) Loprazolam;
452	452
453	453	(30) Lorazepam;
454	454
455	455	(31) Lormetazepam;
456	456
457	457	(32) Mebutamate;
458	458
459	459	(33) Medazepam;
460	460
461	461	(34) Meprobamate;
462	462
463	463	(35) Methohexital;
464	464
465	465	(36) Methylphenobarbital (mephorbarbital);
466	466
467	467	(37) Midazolam;
468	468
469	469	(38) Nimetazepam;
470	470
471	471	(39) Nitrazepam;
472	472
473	473	(40) Nordiazepam;
474	474
475	475	(41) Oxazepam;
476	476
477	477	(42) Oxazolam;
478	478
479	479	(43) Paraldehyde;
480	480
481	481	(44) Petrichloral;
482	482
483	483	(45) Phenobarbital;
484	484
485	485	(46) Pinazepam;
486	486
487	487	(47) Prazepam;
488	488
489	489	(48) Quazepam;
490	490
491	491	(49) Suvorexant;
492	492
493	493	(50) Temazepam;
494	494
495	495	(51) Tetrazepam;
496	496
497	497	(52) Triazolam;
498	498
499	499	(53) Zaleplon;
500	500
501	501	(54) Zolpidem;
502	502
503	503	(55) Zopiclone (Lunesta); [and]
504	504
505	505	(56) Brexanolone[.];
506	506
507	507	(57) Remimazolam, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible; and
508	508
509	509	(58) Lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible."
510	510
511	511	(2) By amending subsection (d) to read as follows:
512	512
513	513	"(d) Stimulants. Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
514	514
515	515	(1) Cathine ((+)-norpseudoephedrine);
516	516
517	517	(2) Diethylpropion;
518	518
519	519	(3) Fencamfamin;
520	520
521	521	(4) Fenproporex;
522	522
523	523	(5) Mazindol;
524	524
525	525	(6) Mefenorex;
526	526
527	527	(7) Modafinil;
528	528
529	529	(8) Phentermine;
530	530
531	531	(9) Pemoline (including organometallic complexes and chelates thereof);
532	532
533	533	(10) Pipradrol;
534	534
535	535	(11) Sibutramine;
536	536
537	537	(12) SPA (1-dimethylamino-1,2-diphenylethane, lefetamine);
538	538
539	539	(13) Lorcaserin; [and]
540	540
541	541	(14) Solriamfetol[.]; and
542	542
543	543	(15) Serdexmethylphenidate, including its salts, isomers, and salts of isomers."
544	544
545	545	SECTION 4. Section 329-22, Hawaii Revised Statutes, is amended by amending subsection (d) to read as follows:
546	546
547	547	"(d) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers:
548	548
549	549	(1) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy- propionamide], (Vimpat);
550	550
551	551	(2) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid]; [and]
552	552
553	553	(3) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) (Other names: BRV; UCB-34714; Briviact) and its salts[.]; and
554	554
555	555	(4) Lasmiditan (2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide)."
556	556
557	557	SECTION 5. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
558	558
559	559	SECTION 6. This Act shall take effect upon its approval.
560	560
561	561
562	562
563	563	INTRODUCED BY: _____________________________
564	564	BY REQUEST
565	565
566	566	INTRODUCED BY:
567	567
568	568	_____________________________
569	569
570	570
571	571
572	572
573	573
574	574	BY REQUEST
575	575
576	576	Report Title: Uniform Controlled Substances Act Description: Updates the Uniform Controlled Substances Act, chapter 329, Hawaii Revised Statutes, to make it consistent with amendments in the federal controlled substances law as required by section 329-11, Hawaii Revised Statutes. The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
577	577
578	578
579	579
580	580
581	581
582	582	Report Title:
583	583
584	584	Uniform Controlled Substances Act
585	585
586	586
587	587
588	588	Description:
589	589
590	590	Updates the Uniform Controlled Substances Act, chapter 329, Hawaii Revised Statutes, to make it consistent with amendments in the federal controlled substances law as required by section 329-11, Hawaii Revised Statutes.
591	591
592	592
593	593
594	594
595	595
596	596
597	597
598	598	The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.